Curative Biotechnology Inc (CUBT) — Cash Flow Reinvestment Rate

Latest as of December 2022: 0.00x

Curative Biotechnology Inc (CUBT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2022, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $135.81K. Check CUBT cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

$0.00
Capex + Investments

Operating Cash Flow

$135.81K
USD

Capital Expenditures

$0.00
USD

Curative Biotechnology Inc Cash Flow Reinvestment Rate (2015–2015)

Historical reinvestment intensity for Curative Biotechnology Inc across 1 annual periods. Explore CUBT operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for Curative Biotechnology Inc (2015–2015)

Year-by-year capital reinvestment analysis for Curative Biotechnology Inc. For live market cap and broader valuation context, see Curative Biotechnology Inc (CUBT) market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2015 0.00x $0.00 $1.96K $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow